Key result
Minimal dose heparin during hemodialysis matches conventional blood loss with markedly reduced dosage and no bleeding.
Why the study?
Minimal dose heparinization inhibiting clotting factors IXa, Xa, XIa during hemodialysis was compared with conventional heparinization methods to evaluate efficacy and safety.
Does minimal dose heparinization reduce heparin dosage and bleeding problems compared to conventional heparinization in patients undergoing hemodialysis?
Does minimal dose heparinization reduce heparin dosage and bleeding problems compared to conventional heparinization in patients undergoing hemodialysis?
Minimal dose heparinization during hemodialysis effectively reduces heparin dosage without increasing blood loss or bleeding complications, even in high-risk patients.
Answers are grounded in this paper and cite their sources.
Minimal-dose heparinization may reduce exposure in hemodialysis; leaves open prospective confirmation of safety versus conventional regimens.
Minimal dose heparinization inhibiting clotting factor IXa, Xa, XIa, as monitored by the activated partial thromboplastin time, was compared with conventional intermittent, continuous and regional heparinization during hemodialysis treatment. Blood loss in coil dialyzers was the same. Heparin dosage was reduced markedly. Protamine sulfate and infusion equipment were not required. No bleeding problems were encountered in high-risk patients.
No takes yet. Share an insight, caveat, or question.
Willimann et al. (2008) studied Hemodialysis. Minimal dose heparinization vs. Conventional intermittent, continuous and regional heparinization was evaluated on Blood loss in coil dialyzers and bleeding problems. Minimal dose heparinization during hemodialysis resulted in similar blood loss compared to conventional methods, markedly reduced heparin dosage, and no bleeding problems in high-risk patients.
Synapse has enriched 10 related papers. Consider them for comparative context: